Underlying profit rose 19% to NZ$106.6m and IFRS profit after tax climbed 26% to NZ$127.2m year-over-year. Record first-half sales, strong care EBITDA growth, and continued expansion in Australia highlight robust performance.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.